2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Xontogeny, LLC | — | 1,617,000 | Feb 3, 2021 |
| Perceptive Advisors Llc | Director | 1,611,699 | Feb 5, 2024 |
| Perceptive Life Sciences Master Fund Ltd | Director | 1,611,699 | Feb 5, 2024 |
| Edelman Joseph | Director | 1,611,699 | Feb 5, 2024 |
| Perceptive Xontogeny Venture Fund, LP | Director | 1,611,699 | Feb 5, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Jan 23, 2026 | Violin Jonathan | Director | Neutral | 47.5 | -263,321 | -100.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Morabito Christopher | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Milne Jill C. | CEO | Neutral | 47.5 | -4,377 | -100.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Matthews Andrea | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Komjathy Andrew | Chief Commercial Officer | Neutral | 47.5 | -100 | -100.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Harshbarger Benjamin | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Clauser Noah | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 23, 2026 | Jan 23, 2026 | AGARWAL SUNIL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | AGARWAL SUNIL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 12, 2025 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Milne Jill C. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Matthews Andrea | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Komjathy Andrew | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Harshbarger Benjamin | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Clauser Noah | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 21, 2025 | Mar 25, 2025 | Morabito Christopher | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2024 | Jun 6, 2024 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 8, 2024 | Apr 9, 2024 | AGARWAL SUNIL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 9, 2024 | AGARWAL SUNIL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 1, 2024 | Apr 3, 2024 | Morabito Christopher | Chief Medical Officer | Sell | 10.0 | -10,000 | -100.00% | ✓ | $135.9K |
| Feb 8, 2024 | Feb 12, 2024 | Morabito Christopher | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 12, 2024 | Milne Jill C. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 12, 2024 | Matthews Andrea | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 12, 2024 | Komjathy Andrew | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 12, 2024 | Harshbarger Benjamin | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 8, 2024 | Feb 12, 2024 | Clauser Noah | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | PERCEPTIVE ADVISORS LLC | Director | Buy | 100.0 | +2,481,350 | 103.72% | ✗ | $30M |
| Jan 26, 2024 | Jan 30, 2024 | Morabito Christopher | Chief Medical Officer | Sell | 10.0 | -10,000 | -100.00% | ✓ | $111.4K |
| Dec 21, 2023 | Dec 22, 2023 | PERCEPTIVE ADVISORS LLC | Director | Buy | 100.0 | +740,000 | 44.78% | ✗ | $4.6M |
| Oct 16, 2023 | Oct 18, 2023 | PERCEPTIVE ADVISORS LLC | Director | Buy | 100.0 | +1,074,608 | 49.08% | ✗ | $7M |
| Jun 2, 2023 | Jun 6, 2023 | Milne Jill C. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Matthews Andrea | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Komjathy Andrew | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Harshbarger Benjamin | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Morabito Christopher | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Clauser Noah | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2023 | Apr 19, 2023 | Matthews Andrea | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2023 | Matthews Andrea | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 19, 2022 | Dec 21, 2022 | PERCEPTIVE ADVISORS LLC | Director | Buy | 100.0 | +908,265 | 698.43% | ✗ | $10M |
| Aug 1, 2022 | Aug 2, 2022 | Morabito Christopher | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 15, 2022 | Morabito Christopher | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 9, 2022 | Jun 21, 2022 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 21, 2022 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 21, 2022 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 21, 2022 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 21, 2022 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 21, 2022 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 21, 2022 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 1, 2022 | Mar 3, 2022 | Harshbarger Benjamin | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 1, 2022 | Mar 3, 2022 | Clauser Noah | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 1, 2022 | Mar 3, 2022 | Milne Jill C. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 1, 2022 | Mar 3, 2022 | Nichols Andrew John | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 1, 2022 | Mar 3, 2022 | Komjathy Andrew | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 28, 2021 | Feb 10, 2022 | Komjathy Andrew | Chief Commercial Officer | Neutral | 27.5 | -90 | -47.37% | ✗ | - |
| Nov 19, 2021 | Nov 23, 2021 | Komjathy Andrew | Chief Commercial Officer | Buy | 90.0 | +100 | 100.00% | ✗ | $669.5 |
| Sep 20, 2021 | Sep 22, 2021 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2021 | Jun 10, 2021 | Harshbarger Benjamin | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Komjathy Andrew | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Nichols Andrew John | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Callori Fred | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Violin Jonathan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Clauser Noah | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | KISHBAUCH MICHAEL D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | BATE KENNETH | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Beck Joanne T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Milne Jill C. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | Cole Hugh M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2021 | Jun 2, 2021 | LAPOINTE ANTHONY GREGG | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |